GRAL Straddle Strategy

GRAL (GRAIL, Inc.), in the Healthcare sector, (Medical - Diagnostics & Research industry), listed on NASDAQ.

GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. The company was incorporated in 2015 and is based in Menlo Park, California. GRAIL, Inc. operates as a former subsidiary of Illumina, Inc.

GRAL (GRAIL, Inc.) trades in the Healthcare sector, specifically Medical - Diagnostics & Research, with a market capitalization of approximately $2.60B, a beta of 3.04 versus the broader market, a 52-week range of 29.95-118.84, average daily share volume of 1.3M, a public-listing history dating back to 2024, approximately 1K full-time employees. These structural characteristics shape how GRAL stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 3.04 indicates GRAL has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.

What is a straddle on GRAL?

A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.

Current GRAL snapshot

As of May 15, 2026, spot at $59.75, ATM IV 91.70%, IV rank 16.08%, expected move 26.29%. The straddle on GRAL below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 63-day expiry.

Why this straddle structure on GRAL specifically: GRAL IV at 91.70% is on the cheap side of its 1-year range, which favors premium-buying structures like a GRAL straddle, with a market-implied 1-standard-deviation move of approximately 26.29% (roughly $15.71 on the underlying). The 63-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated GRAL expiries trade a higher absolute premium for lower per-day decay. Position sizing on GRAL should anchor to the underlying notional of $59.75 per share and to the trader's directional view on GRAL stock.

GRAL straddle setup

The GRAL straddle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With GRAL near $59.75, the first option leg uses a $60.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed GRAL chain at a 63-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 GRAL shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Call$60.00$8.85
Buy 1Put$60.00$8.80

GRAL straddle risk and reward

Net Premium / Debit
-$1,765.00
Max Profit (per contract)
Unbounded
Max Loss (per contract)
-$1,759.48
Breakeven(s)
$42.35, $77.65
Risk / Reward Ratio
Unbounded

Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.

GRAL straddle payoff curve

Modeled P&L at expiration across a range of underlying prices for the straddle on GRAL. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

Underlying Price% From SpotP&L at Expiration
$0.01-100.0%+$4,234.00
$13.22-77.9%+$2,913.01
$26.43-55.8%+$1,592.01
$39.64-33.7%+$271.02
$52.85-11.5%-$1,049.98
$66.06+10.6%-$1,159.03
$79.27+32.7%+$161.97
$92.48+54.8%+$1,482.96
$105.69+76.9%+$2,803.96
$118.90+99.0%+$4,124.95

When traders use straddle on GRAL

Straddles on GRAL are pure-volatility plays that profit from large moves in either direction; traders typically buy GRAL straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.

GRAL thesis for this straddle

The market-implied 1-standard-deviation range for GRAL extends from approximately $44.04 on the downside to $75.46 on the upside. A GRAL long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. Current GRAL IV rank near 16.08% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on GRAL at 91.70%. As a Healthcare name, GRAL options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to GRAL-specific events.

GRAL straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. GRAL positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move GRAL alongside the broader basket even when GRAL-specific fundamentals are unchanged. Always rebuild the position from current GRAL chain quotes before placing a trade.

Frequently asked questions

What is a straddle on GRAL?
A straddle on GRAL is the straddle strategy applied to GRAL (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With GRAL stock trading near $59.75, the strikes shown on this page are snapped to the nearest listed GRAL chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are GRAL straddle max profit and max loss calculated?
Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the GRAL straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 91.70%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$1,759.48 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a GRAL straddle?
The breakeven for the GRAL straddle priced on this page is roughly $42.35 and $77.65 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current GRAL market-implied 1-standard-deviation expected move is approximately 26.29%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a straddle on GRAL?
Straddles on GRAL are pure-volatility plays that profit from large moves in either direction; traders typically buy GRAL straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
How does current GRAL implied volatility affect this straddle?
GRAL ATM IV is at 91.70% with IV rank near 16.08%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

Related GRAL analysis